Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment

Somaiyeh Malekghasemi ¹ , Jafar Majidi ^2,3, Amir Baghbanzadeh ¹, Jalal Abdolalizadeh ⁴, Behzad Baradaran ^2,3 * , Leili Aghebati-Maleki ^2,3 *

Cited by CrossRef: 46

1- Cui M, Liu Y, Cheng L, Li T, Deng Y, Liu D. Research progress on anti-ovarian cancer mechanism of miRNA regulating tumor microenvironment. Front Immunol. 2022;13 [Crossref]

2- Zhuang X, Li B, Liu X, Fan T, Lan X, Wang X, Yu M. The colorectal cancer-specific microbiome regulation and immune response activation via an artificial biomimetic nanovaccine. Chemical Engineering Journal. 2023;461:141982 [Crossref]

3- Wang S, Kuai Y, Lin S, Li L, Gu Q, Zhang X, Li X, He Y, Chen S, Xia X, Ruan Z, Lin C, Ding Y, Zhang Q, Qi C, Li J, He X, Pathak J, Zhou W, Liu S, Wang L, Zheng L. NF-κB Activator 1 downregulation in macrophages activates STAT3 to promote adenoma-adenocarcinoma transition and immunosuppression in colorectal cancer. BMC Med. 2023;21(1) [Crossref]

4- Qiu X, Zhao T, Luo R, Qiu R, Li Z. Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer. Front Oncol. 2022;12 [Crossref]

5- da Costa V, Freire T. Advances in the Immunomodulatory Properties of Glycoantigens in Cancer. Cancers. 2022;14(8):1854 [Crossref]

6- Li F, Zheng X, Wang X, Xu J, Zhang Q. Macrophage polarization synergizes with oxaliplatin in lung cancer immunotherapy via enhanced tumor cell phagocytosis. Translational Oncology. 2021;14(11):101202 [Crossref]

7- Ferdosnejad K, Zamani M, Soroush E, Fateh A, Siadat S, Tarashi S. Tuberculosis and lung cancer: metabolic pathways play a key role. Nucleosides, Nucleotides & Nucleic Acids. 2024;43(11):1262 [Crossref]

8- De Gregorio A, Krasnowska E, Zonfrillo M, Ravagnan G, Bordignon V, Bonmassar E, Fuggetta M. Influence of Polydatin on the Tumor Microenvironment In Vitro: Studies with a Colon Cancer Cell Model. IJMS. 2022;23(15):8442 [Crossref]

9- Wang Z, Ning Z, Ma C, Liu T, Tao B, Guo L. Low expression of lysosome-related genes KCNE1, NPC2, and SFTPD promote cancer cell proliferation and tumor associated M2 macrophage polarization in lung adenocarcinoma. Heliyon. 2024;10(6):e27575 [Crossref]

10- Decollogny M, Rottenberg S. Persisting cancer cells are different from bacterial persisters. Trends in Cancer. 2024;10(5):393 [Crossref]

11- Brindisi M, Frattaruolo L, Fiorillo M, Dolce V, Sotgia F, Lisanti M, Cappello A. New insights into cholesterol‐mediated ERRα activation in breast cancer progression and pro‐tumoral microenvironment orchestration. The FEBS Journal. 2023;290(6):1481 [Crossref]

12- Ahmad R, Eubank T, Lukomski S, Boone B. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer. Biomolecules. 2021;11(6):901 [Crossref]

13- Wang X, Wei S, Li W, Wei X, Zhang C, Dai S, Ma M, Zhao L, Shan B. P-Hydroxylcinnamaldehyde induces tumor-associated macrophage polarization toward the M1 type by regulating the proteome and inhibits ESCC in vivo and in vitro. International Immunopharmacology. 2023;119:110213 [Crossref]

14- Wu Y, Xiao Y, Ding Y, Ran R, Wei K, Tao S, Mao H, Wang J, Pang S, Shi J, Zhu C, Wan W, Yang Q, Chen C. Colorectal cancer cell-derived exosomal miRNA-372-5p induces immune escape from colorectal cancer via PTEN/AKT/NF-κB/PD-L1 pathway. International Immunopharmacology. 2024;143:113261 [Crossref]

15- Wang H, Tian T, Zhang J. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis. IJMS. 2021;22(16):8470 [Crossref]

16- Tajbakhsh A, Yousefi F, Farahani N, Savardashtaki A, Reiner Ž, Jamialahmadi T, Sahebkar A. Molecular Mechanisms and Therapeutic Potential of Resolvins in Cancer - Current Status and Perspectives. CMC. 2024;31(36):5898 [Crossref]

17- Deng Z, Qishan S, Zhang Q, Wang J, Yue Y, Geng L, Wu N. Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin. Biomedicine & Pharmacotherapy. 2024;173:116360 [Crossref]

18- Matsuoka T, Yashiro M. Molecular Mechanism for Malignant Progression of Gastric Cancer Within the Tumor Microenvironment. IJMS. 2024;25(21):11735 [Crossref]

19- Travers J, Rohan J, Sahu R. New Insights Into the Pathologic Roles of the Platelet-Activating Factor System. Front Endocrinol. 2021;12 [Crossref]

20- Yordanov A, Damyanova P, Vasileva-Slaveva M, Hasan I, Kostov S, Shivarov V. Integrated Analysis of Phagocytic and Immunomodulatory Markers in Cervical Cancer Reveals Constellations of Potential Prognostic Relevance. IJMS. 2024;25(16):9117 [Crossref]

21- Rakshit S, Roy T, Jana P, Gupta K. A Comprehensive Review on the Importance of Sustainable Synthesized Coinage Metal Nanomaterials and Their Diverse Biomedical Applications. Biol Trace Elem Res. 2024; [Crossref]

22- Satish M, Ayyathurai M, Mahadevan S, Ramadas M. Tumor Microenvironment and its Role in Metastasis. JRAD. 2022;14(1):28 [Crossref]

23- Abdul-Rahman T, Ghosh S, Badar S, Nazir A, Bamigbade G, Aji N, Roy P, kachani H, Garg N, Lawal L, Bliss Z, Wireko A, Atallah O, Adebusoye F, Teslyk T, Sikora K, Horbas V. The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review. Eur J Med Res. 2024;29(1) [Crossref]

24- Aggarwal A, Khalighi S, Babu D, Li H, Azarianpour-Esfahani S, Corredor G, Fu P, Mokhtari M, Pathak T, Thayer E, Modesitt S, Mahdi H, Avril S, Madabhushi A. Computational pathology identifies immune-mediated collagen disruption to predict clinical outcomes in gynecologic malignancies. Commun Med. 2024;4(1) [Crossref]

25- Benaiges E, Ceperuelo-Mallafré V, Madeira A, Bosch R, Núñez-Roa C, Ejarque M, Maymó-Masip E, Huber-Ruano I, Lejeune M, Vendrell J, Fernández-Veledo S. Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity. Cell Oncol. 2021;44(4):777 [Crossref]

26- Frosch J, Leontari I, Anderson J. Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment. Cancers. 2021;13(7):1743 [Crossref]

27- Umakoshi M, Nakamura A, Tsuchie H, Li Z, Kudo-Asabe Y, Miyabe K, Ito Y, Yoshida M, Nagasawa H, Okada K, Nanjo H, Maeda D, Miyakoshi N, Tanaka M, Goto A. Macrophage numbers in the marginal area of sarcomas predict clinical prognosis. Sci Rep. 2023;13(1) [Crossref]

28- Xing Y, Ruan G, Ni H, Qin H, Chen S, Gu X, Shang J, Zhou Y, Tao X, Zheng L. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression. Front Immunol. 2021;12 [Crossref]

29- Vakhshiteh F, Bagheri Z, Soleimani M, Ahvaraki A, Pournemat P, Alavi S, Madjd Z. Heterotypic tumor spheroids: a platform for nanomedicine evaluation. J Nanobiotechnol. 2023;21(1) [Crossref]

30- Liu X, Yin L, Shen S, Hou Y. Inflammation and cancer: paradoxical roles in tumorigenesis and implications in immunotherapies. Genes & Diseases. 2023;10(1):151 [Crossref]

31- Jia F, Jing S, Guo J. m6A regulator-mediated methylation modifications define the immune infiltration characteristics of the tumor microenvironment in prostate adenocarcinoma. Sci Rep. 2024;14(1) [Crossref]

32- Duan S, Wang S, Huang T, Wang J, Yuan X. circRNAs: Insight Into Their Role in Tumor-Associated Macrophages. Front Oncol. 2021;11 [Crossref]

33- Wang D. The role and research progress of tumor-associated macrophages in cervical cancer. Am J Cancer Res. 2024;14(12):5999 [Crossref]

34- Dudzinski S, Bader J, Beckermann K, Young K, Hongo R, Madden M, Abraham A, Reinfeld B, Ye X, MacIver N, Giorgio T, Rathmell J. Leptin Augments Antitumor Immunity in Obesity by Repolarizing Tumor-Associated Macrophages. 2021;207(12):3122 [Crossref]

35- Wang X, Li X, Wang X. Identification of immune microenvironment subtypes that predicted the prognosis of patients with ovarian cancer. J Cellular Molecular Medi. 2021;25(8):4053 [Crossref]

36- Bai J, Zhang X, Meng W, Xu H, Liu Y, Zhong Y, Lin X, Wang J, fan D, Lv G, Gu Y. Dioscin decreases M2 polarization via inhibiting a positive feedback loop between RBM47 and NF-κB in glioma. Phytomedicine. 2024;128:155417 [Crossref]

37- Choi Y, Lee D, Kim N, Seo I, Park N, Chong G. Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances. Life. 2024;14(4):443 [Crossref]

38- Sudarskikh T, Larionova I, Rakina M, Kzhyshkowska J. Biomarkers for modeling of cancer-specifc tumorassociated macrophages ex vivo. Sib onkol ž. 2024;23(4):54 [Crossref]

39- Gluba-Brzózka A, Rysz J, Ławiński J, Franczyk B. Renal Cell Cancer and Obesity. IJMS. 2022;23(6):3404 [Crossref]

40- Raj A, Babu A, Kothandan V, Park I, Hwang S. Development of nano-immunotherapy for cancer treatment: achievements and scopes. J Pharm Investig. 2023;53(6):827 [Crossref]

41- Li S, Hao L, Hu X. Biological Roles and Clinical Therapeutic Applications of Tumor-Associated Macrophages in Colorectal Liver Metastasis. JIR. 2024;Volume 17:8429 [Crossref]

42- Li C, Xu Y, Zhang J, Zhang Y, He W, Ju J, Wu Y, Wang Y. The effect of resveratrol, curcumin and quercetin combination on immuno-suppression of tumor microenvironment for breast tumor-bearing mice. Sci Rep. 2023;13(1) [Crossref]

43- Jung M, Bonavida B. Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs . Crit Rev Oncog. 2024;29(4):1 [Crossref]

44- Matsuo K, Yoshie O, Nakayama T. Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers. 2021;13(23):6132 [Crossref]

45- Sampaio-Ribeiro G, Ruivo A, Silva A, Santos A, Oliveira R, Gama J, Cipriano M, Tralhão J, Paiva A. Innate Immune Cells in the Tumor Microenvironment of Liver Metastasis from Colorectal Cancer: Contribution to a Comprehensive Therapy. Cancers. 2023;15(12):3222 [Crossref]

46- Hu M, Fan J, He Z, Zeng J. The regulatory role of autophagy between TAMs and tumor cells. Cell Biochemistry & Function. 2024;42(2) [Crossref]

47- Guo J, Wang M, Zhu Y, Watari F, Xu Y, Chen X. Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment. 2023;2(2) [Crossref]

48- Zhang H, Li Y. Targeting the breast tumor microenvironment by plant-derived products and their nanoformulations. Journal of Drug Delivery Science and Technology. 2024;93:105432 [Crossref]